Why couldn't it be for sale?
posted on
Mar 15, 2014 07:55AM
This company could be outright sold, it says so right in the CP. Two paths actually single or multiple aquirers. I see no changes on the CP that suggest this has been taken off the table. They would have to develop the company regardless to add value either way, as they currently have no revenue. I am seeing three possible outcomes. This could go either way. Note the last line copied below, could this be why they are exercising caution right now?
Several Options to Monetize POET
POET is a research company, not a product company
POET/PET are ready to enter the commercialization process
No single company is currently active in all market areas where POET provides a best-
in-class value proposition; syndicate needed to extract full value from technology
platform
Single Acquirer
This path would involve selling POET to a single (by definition large) 3rd party
Technology access/investment would likely be syndicated by acquirer
Relatively small number of viable candidates
Multiple Acquirers
This path would involve selling POET to a syndicate (likely structured as a joint
venture)
Ideal syndicate would include members with market presence in all key areas related
to POET commercialization
• Licensing
Certain specialized market segments might be best addressed by licensing all or part
of the POET/PET technology to one or more 3rd parties for use in a given market
Can be complex with difficult-to-foresee implications for other activities